Kuangli Bio-Tech Holdings , Ltd. Receivables

Kuangli Bio-Tech Holdings , Ltd. (6431.TW) currently reports a receivables of $78M as of June 2026. That compares with $86M in the prior-year period — down 8.9% year over year. Use the charts on this page to explore Kuangli Bio-Tech Holdings , Ltd.'s receivables history and peer comparisons.

Kuangli Bio-Tech Holdings , Ltd.'s receivables decreased from $86M to $78M — a 8.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kuangli Bio-Tech Holdings , Ltd. reported $78M in receivables as of June 2026. That compares with $86M in the prior-year period — down 8.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $78M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kuangli Bio-Tech Holdings , Ltd., and consider following 6431.TW for alerts when major investors trade the stock.